Login / Signup

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.

Uraujh Yousaf-KhanCarlijn van der AalstPim A de JongMarjolein HeuvelmansErnst Th ScholtenJan-Willem LammersPeter van OoijenKristiaan NackaertsCarla WeeninkHarry GroenRozemarijn VliegenthartKevin Ten HaafMatthijs OudkerkHarry de Koning
Published in: Thorax (2016)
ISRCTN63545820.
Keyphrases
  • clinical trial
  • study protocol
  • randomized controlled trial
  • phase iii